BioNexus Gene Lab Corp Common stock (BGLC)vsSouthern Copper Corporation (SCCO)
BGLC
BioNexus Gene Lab Corp Common stock
$0.92
-6.98%
BASIC MATERIALS · Cap: $3.60M
SCCO
Southern Copper Corporation
$177.53
-7.42%
BASIC MATERIALS · Cap: $169.30B
Smart Verdict
WallStSmart Research — data-driven comparison
Southern Copper Corporation generates 504841% more annual revenue ($15.79B vs $3.13M). SCCO leads profitability with a 35.9% profit margin vs -82.4%. SCCO earns a higher WallStSmart Score of 65/100 (B-).
BGLC
Avoid26
out of 100
Grade: F
SCCO
Strong Buy65
out of 100
Grade: B-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 47 in profit
Keeps 36 of every $100 in revenue as profit
Strong operational efficiency at 61.2%
Revenue surging 40.6% year-over-year
Earnings expanding 71.6% YoY
Safe zone — low bankruptcy risk
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -35.9% — below average capital efficiency
Revenue declined 96.6%
Moderate valuation
Trading at 12.1x book value
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : BGLC
The strongest argument for BGLC centers on Price/Book, Debt/Equity, Altman Z-Score.
Bull Case : SCCO
The strongest argument for SCCO centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 35.9% and operating margin at 61.2%. Revenue growth of 40.6% demonstrates continued momentum.
Bear Case : BGLC
The primary concerns for BGLC are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : SCCO
The primary concerns for SCCO are P/E Ratio, Price/Book, PEG Ratio.
Key Dynamics to Monitor
BGLC profiles as a turnaround stock while SCCO is a growth play — different risk/reward profiles.
BGLC carries more volatility with a beta of 2.20 — expect wider price swings.
SCCO is growing revenue faster at 40.6% — sustainability is the question.
SCCO generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
SCCO scores higher overall (65/100 vs 26/100), backed by strong 35.9% margins and 40.6% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BioNexus Gene Lab Corp Common stock
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
Southern Copper Corporation
BASIC MATERIALS · COPPER · USA
Southern Copper Corporation is engaged in the extraction, exploration, smelting and refining of copper and other minerals in Peru, Mexico, Argentina, Ecuador and Chile.
Visit Website →Compare with Other SPECIALTY CHEMICALS Stocks
Want to dig deeper into these stocks?